Cost-effectiveness analysis of treatment modalities for women with high-intermediate risk endometrial carcinoma: should Gynecologic Oncology Group (GOG) 249 have included a chemotherapy-only arm?

352 - Poster Session B
Cost-effectiveness analysis of treatment modalities for women with high-intermediate risk endometrial carcinoma: should Gynecologic Oncology Group (GOG) 249 have included a chemotherapy-only arm?

Sunday, March 23, 2014: 10:20 AM

West Exhibit Hall (Tampa Convention Center)

E. E. Landers, R. C. Arend, J. M. Straughn Jr. and C. A. Leath III
University of Alabama at Birmingham, Birmingham, AL